Catalyst Pharmaceuticals, Inc.

16.08 USD
+0.20 (+1.26%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Catalyst Pharmaceuticals, Inc. stock is up 6.84% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 17 May’s closed higher than April. In the last 3 Unusual Options Trades, there were 3 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
18 Apr 13:45 21 Jun, 2024 12.50 CALL 100 366
25 Apr 13:46 21 Jun, 2024 12.50 CALL 100 310
13 May 18:13 21 Jun, 2024 12.50 CALL 100 421

About Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS) and Ruzurgi.